Unknown

Dataset Information

0

Lentivector integration sites in ependymal cells from a model of metachromatic leukodystrophy: non-B DNA as a new factor influencing integration.


ABSTRACT: The blood-brain barrier controls the passage of molecules from the blood into the central nervous system (CNS) and is a major challenge for treatment of neurological diseases. Metachromatic leukodystrophy is a neurodegenerative lysosomal storage disease caused by loss of arylsulfatase A (ARSA) activity. Gene therapy via intraventricular injection of a lentiviral vector is a potential approach to rapidly and permanently deliver therapeutic levels of ARSA to the CNS. We present the distribution of integration sites of a lentiviral vector encoding human ARSA (LV-ARSA) in murine brain choroid plexus and ependymal cells, administered via a single intracranial injection into the CNS. LV-ARSA did not exhibit a strong preference for integration in or near actively transcribed genes, but exhibited a strong preference for integration in or near satellite DNA. We identified several genomic hotspots for LV-ARSA integration and identified a consensus target site sequence characterized by two G-quadruplex-forming motifs flanking the integration site. In addition, our analysis identified several other non-B DNA motifs as new factors that potentially influence lentivirus integration, including human immunodeficiency virus type-1 in human cells. Together, our data demonstrate a clinically favorable integration site profile in the murine brain and identify non-B DNA as a potential new host factor that influences lentiviral integration in murine and human cells.

SUBMITTER: McAllister RG 

PROVIDER: S-EPMC4221599 | biostudies-literature | 2014 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Lentivector integration sites in ependymal cells from a model of metachromatic leukodystrophy: non-B DNA as a new factor influencing integration.

McAllister Robert G RG   Liu Jiahui J   Woods Matthew W MW   Tom Sean K SK   Rupar C Anthony CA   Barr Stephen D SD  

Molecular therapy. Nucleic acids 20140826


The blood-brain barrier controls the passage of molecules from the blood into the central nervous system (CNS) and is a major challenge for treatment of neurological diseases. Metachromatic leukodystrophy is a neurodegenerative lysosomal storage disease caused by loss of arylsulfatase A (ARSA) activity. Gene therapy via intraventricular injection of a lentiviral vector is a potential approach to rapidly and permanently deliver therapeutic levels of ARSA to the CNS. We present the distribution of  ...[more]

Similar Datasets

| S-EPMC5027970 | biostudies-literature
| S-EPMC7379712 | biostudies-literature
| S-EPMC5834549 | biostudies-literature
| S-EPMC3743609 | biostudies-other
| S-EPMC7606900 | biostudies-literature
2013-11-21 | GSE23350 | GEO
| S-EPMC7034505 | biostudies-literature
| S-EPMC4994355 | biostudies-literature
| S-EPMC8842918 | biostudies-literature
| S-EPMC6117375 | biostudies-literature